December 2023

OSAKA, Japan, Dec. 21, 2023 /PRNewswire/ — Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) today announced that it has entered into a discovery collaboration agreement with EVQLV, INC (Miami, Florida USA; CEO: Andrew Satz; “EVQLV”), to

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: